FDA rejects Kala's dry eye drug; Troubled Insys finds a buyer (of some assets) in Hikma
→ Kala Pharmaceuticals, one of the plethora of biotechs that trace their roots to the prolific lab at MIT led by Bob Langer, on Thursday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
